Form 10-QT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001567892-17-000010
Filing Date
2017-02-07
Accepted
2017-02-07 16:36:34
Documents
101
Period of Report
2016-12-30

Document Format Files

Seq Description Document Type Size
1 10-QT mnk10-qt123016.htm 10-QT 1883066
2 EXHIBIT 10.1 mnkexhibit101123016.htm EX-10.1 63150
3 EXHIBIT 10.2 mnkexhibit102123016.htm EX-10.2 74746
4 EXHIBIT 31.1 mnkexhibit311123016.htm EX-31.1 20202
5 EXHIBIT 31.2 mnkexhibit312123016.htm EX-31.2 20246
6 EXHIBIT 32.1 mnkexhibit321123016.htm EX-32.1 7596
  Complete submission text file 0001567892-17-000010.txt   13675220

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mnk-20161230.xml EX-101.INS 3715995
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnk-20161230.xsd EX-101.SCH 79565
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnk-20161230_cal.xml EX-101.CAL 110297
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnk-20161230_def.xml EX-101.DEF 611505
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnk-20161230_lab.xml EX-101.LAB 972543
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnk-20161230_pre.xml EX-101.PRE 739298
Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
Type: 10-QT | Act: 34 | File No.: 001-35803 | Film No.: 17579503
SIC: 2834 Pharmaceutical Preparations